• Non-specific inhibition of dipeptidyl peptidases 8/9 by dipeptidyl peptidase 4 inhibitors negatively affects mesenchymal stem cell differentiation 

      Torrecillas‐Baena, Bárbara; Camacho-Cardenosa, Marta; Quesada-Moraga, Enrique; Moreno-Moreno, Paloma; Dorado, G.; Gálvez-Moreno, M. Ángeles; Casado-Díaz, Antonio (MDPI, 2023)
      DPP4 may play a relevant role in MSC differentiation into osteoblasts or adipocytes. Dipeptidyl peptidase 4 (DPP4) inhibitors (DPP4i), such as sitagliptin and vildagliptin, are used as antidiabetic drugs. However, vildagliptin ...
    • Splicing Machinery is Dysregulated in Pituitary Neuroendocrine Tumors and is Associated with Aggressiveness Features 

      Vázquez Borrego, María del Carmen; Fuentes-Fayos, Antonio C.; Venegas-Moreno, Eva; Rivero-Cortés, Esther; Dios, Elena; Moreno Moreno, Paloma; Madrazo-Atutxa, Ainara; Remón, Pablo; Solivera, Juan; Wildemberg, Luiz E.; Kasuki, Leandro; López-Fernández, Judith M.; Gadelha, Mônica R.; Gálvez-Moreno, M. Ángeles; Soto-Moreno, Alfonso; Gahete Ortiz, Manuel D.; Castaño, Justo P.; Luque, Raúl M. (MDPI, 2019)
      Pituitary neuroendocrine tumors (PitNETs) constitute approximately 15% of all brain tumors, and most have a sporadic origin. Recent studies suggest that altered alternative splicing and, consequently, appearance of aberrant ...
    • Valor pronóstico del estudio molecular en la enfermedad de Cushing 

      Moreno Moreno, Paloma (Universidad de Córdoba, UCOPress, 2022)
      La enfermedad de Cushing (EC) se origina por un tumor hipofisario secretor de hormona adrenocorticotrópica (ACTH), que suele presentarse en forma de microadenoma en el 95% de los casos. Los tumores hipofisarios secretores ...